Abemaciclib,Anastrozole,Letrozole,LEE011,Palbociclib
Eli Lilly,Novartis,Pfizer
['evolution']
as we continue to see differential os among the cdk4/6 inhibitors, i suspect varying control of microscopic disease and evolution of resistant clones (not captured by recist/pfs) may be contributing.
great talk by dr. ezquerra suggesting the cdk4/6i s are different. #esmo2022 
Oncologist & researcher at Memorial Sloan Kettering Cancer Center. Working on optimizing lifestyle & metabolic health to improve cancer risk and outcomes.